CONMED Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Los beneficios de CONMED han disminuido a una tasa media anual de -2.7%, mientras que en la industria Medical Equipment los beneficios crecieron en un 13.5% anualmente. Los ingresos han ido creciendo a una tasa media de 7% al año. La rentabilidad financiera de CONMED es de 9.9%, y sus márgenes netos son de 6.5%.

Información clave

-2.7%

Tasa de crecimiento de los beneficios

-4.0%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	8.9%
Tasa de crecimiento de los ingresos	7.0%
Rentabilidad financiera	9.6%
Margen neto	6.5%
Última actualización de beneficios	31 Mar 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Mar 10

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Feb 14

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Feb 02

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Jan 24

ConMed: Still Fairly Priced, Turning More Constructive

Dec 09

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Nov 18

Conmed withdraws FY22 guidance on software implementation-related disruption

Nov 15

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Oct 11

ConMed: Fairly Priced At Pre-Pandemic Market Cap

Sep 21

CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

Sep 03

CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

Aug 18

CONMED declares $0.20 dividend

Aug 11

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?

Jul 20

We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt

Jun 23

Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today

Jun 10

Estimating The Fair Value Of CONMED Corporation (NYSE:CNMD)

May 25

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero CONMED. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NYSE:CNMD Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Mar 24	1,262	82	509	54
31 Dec 23	1,245	64	505	53
30 Sep 23	1,169	58	488	51
30 Jun 23	1,139	88	480	51
31 Mar 23	1,099	-94	462	49
31 Dec 22	1,045	-81	439	47
30 Sep 22	1,069	-83	440	46
30 Jun 22	1,042	-114	427	44
31 Mar 22	1,020	68	420	44
31 Dec 21	1,011	63	415	44
30 Sep 21	989	62	405	44
30 Jun 21	979	54	393	43
31 Mar 21	881	13	369	40
31 Dec 20	862	10	374	40
30 Sep 20	874	0	369	41
30 Jun 20	870	0	373	42
31 Mar 20	951	34	391	45
31 Dec 19	955	29	388	45
30 Sep 19	933	29	383	44
30 Jun 19	901	28	370	43
31 Mar 19	876	31	361	41
31 Dec 18	860	41	353	38
30 Sep 18	840	72	349	36
30 Jun 18	828	73	345	34
31 Mar 18	812	71	337	32
31 Dec 17	796	55	331	32
30 Sep 17	778	15	323	32
30 Jun 17	773	16	318	32
31 Mar 17	769	12	317	32
31 Dec 16	764	15	313	32
30 Sep 16	750	16	306	31
30 Jun 16	735	17	302	30
31 Mar 16	722	22	292	29
31 Dec 15	719	30	287	27
30 Sep 15	723	34	287	28
30 Jun 15	729	27	291	28
31 Mar 15	736	30	296	27
31 Dec 14	740	32	303	28
30 Sep 14	747	31	310	27
30 Jun 14	750	35	308	27
31 Mar 14	753	34	309	27
31 Dec 13	763	36	318	26
30 Sep 13	756	37	308	26
30 Jun 13	760	40	309	26

Ingresos de calidad: CNMD tiene ganancias de alta calidad.

Margen de beneficios creciente: CNMD pasó a ser rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de CNMD han disminuido en un 2.7% al año en los últimos 5 años.

Acelerando crecimiento: CNMD ha pasado a ser rentable en el último año, lo que dificulta la comparación de la tasa de crecimiento de los beneficios con su promedio de 5 años.

Beneficios vs. Industria: CNMD ha pasado a ser rentable en el último año, lo que es difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Medical Equipment (3.3%).

CONMED Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

CONMED Corporation to Report Q1, 2024 Results on Apr 24, 2024

Full year 2023 earnings: EPS misses analyst expectations

Third quarter 2023 earnings: EPS misses analyst expectations

CONMED Corporation to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Recent updates

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

CONMED Corporation Revises Earnings Guidance for the Full Year 2024

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

CONMED Corporation, Annual General Meeting, May 22, 2024

CONMED Corporation to Report Q1, 2024 Results on Apr 24, 2024

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Insider exercised options and sold US$721k worth of stock

Upcoming dividend of US$0.20 per share

CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2024

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Full year 2023 earnings: EPS misses analyst expectations

CONMED Corporation Provides Financial Guidance for the Full Year 2024

Investor sentiment deteriorates as stock falls 17%

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED Corporation Announces Quarterly Cash Dividend, Payable on January 5, 2024

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates fall by 11%

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Price target decreased by 9.5% to US$123

Third quarter 2023 earnings: EPS misses analyst expectations

CONMED Corporation Updates Third Quarter Guidance for 2023

CONMED Corporation to Report Q3, 2023 Results on Oct 25, 2023

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Upcoming dividend of US$0.20 per share at 0.7% yield

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

CONMED Corporation Announces Quarterly Cash Dividend, Payable on October 5, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

CONMED Corporation Revises Earnings Guidance for the Full Year 2023

CONMED Corporation to Report Q2, 2023 Results on Jul 26, 2023

Insider notifies of intention to sell stock

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Upcoming dividend of US$0.20 per share at 0.6% yield

CONMED Corporation Announces Quarterly Cash Dividend, Payable on July 5, 2023

Insider notifies of intention to sell stock

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Insider recently sold US$166k worth of stock

Price target increased by 13% to US$126

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chairman of the Board recently sold US$464k worth of stock

Executive VP & CFO exercised options and sold US$1.2m worth of stock

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Upcoming dividend of US$0.20 per share at 0.8% yield

Special Counsel & Corporate Secretary exercised options and sold US$283k worth of stock

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased by 11% to US$110

CONMED Corporation Provides Earnings Guidance for the Full Year 2023

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

CONMED Corporation to Report Q4, 2022 Results on Feb 02, 2023

Executive VP & CFO exercised options and sold US$174k worth of stock

ConMed: Still Fairly Priced, Turning More Constructive

CONMED Corporation Announces Management Changes

CONMED Corporation Announces Quarterly Cash Dividend, Payable on January 5, 2023

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Now 23% undervalued after recent price drop

CONMED Corporation Provides Revenue Guidance for the Full Year 2023

Insufficient new directors

Conmed withdraws FY22 guidance on software implementation-related disruption

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

CONMED Corporation Revises Earnings Guidance for the Full Year 2022

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

CONMED Corporation to Report Q3, 2022 Results on Oct 26, 2022

Insufficient new directors

Desglose de ingresos y gastos
Beta